Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Cencora Inc.

Corcept Therapeutics ( ($CORT) ) has shared an announcement. On June 17, 2026, Corcept Therapeutics said it had resubmitted its New Drug Applicatio...

Corcept Resubmits FDA Application for Relacorilant in Cushing’s

An announcement from Cencora ( ($COR) ) is now available. On June 15, 2026, Cencora announced that Executive Vice President and Chief Human Resourc...

Cencora announces leadership transition in human resources

Curzon Energy PLC ( ($GB:COR) ) has shared an announcement. Corpus Resources Plc reported a swing to a profit of US$3.47 million for the year ended...

Corpus Resources swings to profit after CVA and raises fresh capital for oil and gas deal hunt

Analysts have been eager to weigh in on the Technology sector with new ratings on Nokia (NOK), Frequency Electronics (FEIM) and comScore (SCOR). No...

Analysts Offer Insights on Technology Companies: Nokia (NOK), Frequency Electronics (FEIM) and comScore (SCOR)

comScore ( ($SCOR) ) has issued an update. On June 10, 2026, comScore, Inc. plans to host an investor conference call at 5:00 p.m. ET, offering a l...

comScore Schedules Investor Call to Discuss Strategic Plans

comScore ( ($SCOR) ) just unveiled an announcement. On June 9, 2026, comScore, Inc. announced that Chief Operating Officer Greg Dale and Head of Me...

comScore Announces Executive Departures and Leadership Consolidation

Shares in Iren Limited ($IREN) and other AI cloud infrastructure and Bitcoin mining companies jumped on Monday afternoon as Bitcoin’s (BTC) price r...

Why Is Iren Stock Rising Today, 6/8/2026?

In a report released on June 5, Jeff Fenwick from ATB Cormark Capital Markets maintained a Buy rating on Canaccord Genuity, with a price target of ...

Canaccord Genuity (CCORF) Gets a Buy from ATB Cormark Capital Markets

In a report released yesterday, from Ventum Financial maintained a Buy rating on Canaccord Genuity, with a price target of C$16.50. In a report rel...

Canaccord Genuity (CCORF) Gets a Buy from Ventum Financial

An update from Procore Technologies ( ($PCOR) ) is now available. At its annual meeting of stockholders held on June 4, 2026, Procore Technologies,...

Procore Shareholders Reelect Directors and Back Governance Measures

Shares in Iren Limited ($IREN), the Australian AI cloud company and Bitcoin miner, tumbled by 14% on Friday afternoon amid the rout facing Bitcoin ...

Why Is Iren Stock Plunging Today, 6/5/2026?

Global Cord Blood ( ($CORBF) ) has issued an announcement. Global Cord Blood Corporation, which has been in court-supervised provisional liquidatio...

Global Cord Blood JPLs File Sixteenth Report in Ongoing Cayman Liquidation

An update from Ecora Royalties PLC ( ($GB:ECOR) ) is now available. Ecora Royalties PLC reported that shareholders approved all resolutions at its ...

Ecora Royalties Wins Strong Shareholder Backing at 2026 AGM

RBC Capital analyst Ben Davis maintained a Buy rating on Ecora Royalties PLC yesterday and set a price target of p185.00. According to TipRanks, Da...

Ecora Royalties PLC (ECOR) Receives a Buy from RBC Capital

Analysts have been eager to weigh in on the Technology sector with new ratings on Unisys (UIS), AvePoint (AVPT) and Core Scientific Inc (CORZ). Uni...

Analysts Conflicted on These Technology Names: Unisys (UIS), AvePoint (AVPT) and Core Scientific Inc (CORZ)

comScore ( ($SCOR) ) has provided an announcement. On May 27, 2026, comScore, Inc. sold its box office measurement, reporting and analytics operati...

comScore Sells Movies Business and Reduces Debt Load

TD Cowen analyst Charles Rhyee maintained a Buy rating on Cencora yesterday and set a price target of $400.00. According to TipRanks, Rhyee is a 4-...

TD Cowen Reaffirms Their Buy Rating on Cencora (COR)

An announcement from Cencora ( ($COR) ) is now available. On May 27, 2026, Cencora announced the appointment of veteran finance executive Eva C. Bo...

Cencora Names New CFO and Reaffirms 2026 Outlook

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on comScore (SCOR), Photronics (PLAB) and MongoDB (MD...

Analysts Conflicted on These Technology Names: comScore (SCOR), Photronics (PLAB) and MongoDB (MDB)

comScore ( ($SCOR) ) has provided an update. On May 28, 2026, Comscore appointed board member and major shareholder Matt McLaughlin as chief execut...

Comscore appoints Matt McLaughlin as new chief executive

Ecora Royalties PLC ( ($GB:ECOR) ) has provided an announcement. Ecora Royalties PLC reported that its Non-Executive Chairman, Andrew Webb, purchas...

Ecora Royalties Chair Increases Stake with Share Purchase

Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Cencora yesterday and set a price target of $331.00. The company’s shares closed yest...

Cencora (COR) Receives a Buy from Wells Fargo

Core Scientific Inc ( ($CORZ) ) has issued an announcement. On May 26, 2026, Core Scientific announced the appointment of Steve Smith to its Board ...

Core Scientific Adds Industry Veteran Steve Smith to Board

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS), Cencora (COR) and Corbus Pharmaceuticals (CRBP). Zo...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	COR	$271.83	-1.90%	3.41M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	COR	$271.83	-1.9%	3.41M
3
4
5
6

COR

COR

Get Cencora Inc. Data in Excel

Get Cencora Inc. Data in Excel